Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
This Month's Featured Content The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Reported by Chris Markoch. Published: 1/18/2026. 
At a Glance - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. That typically means companies with disruptive technologies, those part of emerging trends, or firms with compelling turnaround stories. Many of these companies will never survive or scale, but if even one succeeds, investors can see impressive returns. For investors who believe strength lies in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks. This ranking is based on the number of MarketBeat subscribers following each company. While that's no guarantee of success, it can help bolster an investor's conviction in a stock's potential. What If Washington Declared That: YOUR Money ISN'T Actually Yours?
Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property.
What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want. Get your free guide now by clicking here >> Some investors define a penny stock as any stock trading for $5 or less. The stocks in this screener, however, follow the traditional definition: shares priced under $1. These securities are highly volatile—conduct your own research and understand your risk tolerance before opening a position. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases, including influenza, norovirus, and COVID-19. Unlike traditional injectable vaccines, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility. The bull case for Vaxart hinges on its novel delivery approach. If the company secures FDA approval and can scale manufacturing and distribution, its oral vaccines could reduce logistical barriers to mass immunization and attract significant licensing partnerships. Positive trial results or a commercial collaboration could materially shift sentiment and valuation from the stock's current low base. Clinical risk is the primary challenge. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also constrains visibility. For now, Vaxart is better viewed as a long-term speculative bet on platform validation rather than near-term profitability. The MarketBeat analyst ratings show only one analyst covering the stock—common for small names, but worth noting. VXRT has roughly 18% institutional ownership and about 2% short interest, which may temper some downside volatility. Microvision: Developing Cost-Effective LiDAR Units For Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure, and industrial sensing. The company's hardware and software enable precise 3D mapping needed for self-driving systems and advanced driver-assistance systems (ADAS). Microvision focuses on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case for Microvision rests on two factors: the continued push toward vehicle automation and the potential for partnerships with major automakers. If the company can demonstrate superior performance or cost advantages, it could land supply agreements or licensing deals that improve revenue visibility. Microvision's technology also has potential applications beyond vehicles, including robotics and smart-city infrastructure, which adds optionality to its growth story. Despite the promise, Microvision faces stiff competition from LiDAR players like Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ), and Ouster (NYSE: OUST). The timeline to widespread commercial adoption has repeatedly slipped, and the path to profitability remains uncertain—frustrating many investors. MVIS is covered by three analysts and carries a consensus price target of $2.50, a 169% upside from its Jan. 15 close. Still, Microvision has modest institutional ownership (around 30%) and elevated short interest (about 21%), which can contribute to significant volatility. Long-term investors should be prepared for price swings. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization, and digital asset management. The company helps organizations turn raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain, and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems may overlook. The bullish thesis for Datavault AI rests on its niche focus and scalability potential. As data becomes increasingly valuable, businesses and individuals look for ways to safely monetize digital information. Datavault's technology could benefit from broader AI adoption and rising interest in data sovereignty. Early traction or strategic partnerships could act as catalysts for investor confidence. Still, Datavault AI operates in a highly experimental space. Its business model remains in development, and the path to meaningful revenue growth is unproven. Institutions own less than 1% of the stock, and short interest exceeds 16% as of this writing. Investors considering DVLT should treat it as a long-term, speculative position predicated on belief in data-as-an-asset innovation rather than on near-term earnings potential.
| 
